SPONSORED CONTENT
The 340B program is facing a period of unprecedented change. With the Inflation Reduction Act (IRA) and Medicare’s Maximum Fair Price (MFP) provisions set to take effect in 2026, covered entities can expect significant shifts—most notably, reduced drug reimbursement and
…SPONSORED CONTENT
Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit guidelines, the 340B landscape is constantly evolving. So, it’s no surprise that managing an organization’s 340B program is not easy
…SPONSORED CONTENT
Location: Gaylord National Resort & Convention Center, Fort Washington, MD
340B stakeholders headed to the 340B Coalition Summer Conference 2025 can start their week learning the latest developments in
…SPONSORED CONTENT
In today’s 340B environment, every claim counts. With increased oversight, tighter margins, and growing manufacturer restrictions, covered entities need to maximize their 340B savings by capturing every eligible claim. One often-overlooked opportunity lies in understanding and monitoring disqualified claims.
These are
…
Q: Where did you grow up?
I grew up in Northeast Philadelphia and am a proud product of the Philadelphia public school system. It was a diverse, dynamic environment that taught me how to relate to all kinds of people. I made friends from every background, learned to celebrate differences, and developed a deep appreciation for the power
…SPONSORED CONTENT
The 340B program has morphed into a battlefield of rules, audits, and reporting. For smaller covered entities (CEs), especially rural hospitals and community clinics, keeping pace feels like a losing race. While large health systems deploy entire
…SPONSORED CONTENT
Drug manufacturers defend their unrelenting campaign to reform the 340B program by citing, among other things, the need to protect themselves from the problem of duplicate discounts. Federal law affords such protection for drugs dispensed or administered to Medicaid
…SPONSORED CONTENT
The 340B program has experienced significant changes and disruptions over the past five years, prompting both legislative and judicial action. On May 15, a federal judge rejected efforts by four manufacturers to impose rebate-only
…
SPONSORED CONTENT
TIP: Optimize NDC selection by evaluating utilization, not just 340B accumulations.
When selecting a preferred National Drug
SPONSORED CONTENT
AI is everywhere—chatbots, smart assistants, predictive tools. But in 340B? The line between what’s useful and what’s just marketing is getting blurrier by the day.
We’ve seen AI do
…*Sign up for news summaries and alerts from 340B Report
